Virax Biolabs Group Limited (VRAX) NASDAQ

Currency In USD

AD

Virax Biolabs Group Limited

Address

BioCity Glasgow

Lanarkshire, SC ML1 5UH

United Kingdom of Great Britain and Northern Ireland (the)

Phone

44 20 7788 7414

Sector

Healthcare

Industry

Biotechnology

Employees

26

First IPO Date

July 21, 2022

Key Executives

NameTitlePayYear Born
James FosterChairman, Chief Executive Officer & Principal Accounting Officer477,4521985
Nigel McCrackenChief Operating Officer & Director485,4241965
Lily FuHead of Supply Chain0N/A
Clement MonteilHead of Scientific Research & Development0N/A
AD

Description

Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The company is developing T cell-based test technologies intended to support an immunology profiling platform, with potential applications in post-acute infection syndromes, including Long COVID, and other chronic conditions linked to immune dysregulation.

AD